Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

HPI-4 (CAS 302803-72-1)

0.0(0)
Write a reviewAsk a question

Alternate Names:
Ciliobrevin A
Application:
HPI-4 is a Hedgehog pathway inhibitor
CAS Number:
302803-72-1
Purity:
≥98%
Molecular Weight:
358.18
Molecular Formula:
C17H9Cl2N3O2
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

HPI-4 is a chemical compound known for its specific inhibitory action against Hedgehog (Hh) signaling pathway components, particularly targeting the smoothened (SMO) receptor. The Hh pathway is critical in numerous developmental processes and cellular communication mechanisms. By inhibiting SMO, HPI-4 disrupts the propagation of signals necessary for the transcriptional activation of genes involved in cell growth and differentiation. The primary mechanism of action for HPI-4 involves the direct antagonism of the SMO receptor. This receptor is a key component of the Hh pathway and is responsible for transducing signals to the downstream components of the pathway when activated by the Hedgehog ligand. HPI-4 binds to SMO, preventing its activation and thereby inhibiting the entire signaling cascade. This makes it a useful tool for researchers investigating the molecular details of Hh signaling under physiological and pathological conditions. In research contexts, HPI-4 has been employed to study the role of Hh signaling in various cellular models, providing insights into how this pathway regulates processes like stem cell maintenance and tissue regeneration. The ability of HPI-4 to selectively inhibit Hh signaling has proven instrumental in dissecting the pathway′s contributions to these complex biological phenomena.


HPI-4 (CAS 302803-72-1) References

  1. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade.  |  Hyman, JM., et al. 2009. Proc Natl Acad Sci U S A. 106: 14132-7. PMID: 19666565
  2. Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis.  |  Xiang, W., et al. 2014. Oncol Rep. 32: 1622-30. PMID: 25110171
  3. Effects of the dynein inhibitor ciliobrevin on the flagellar motility of sea urchin spermatozoa.  |  Wada, Y., et al. 2015. Cytoskeleton (Hoboken). 72: 182-92. PMID: 25809136
  4. Specific role of cytoplasmic dynein in the mechanism of action of an antitumor molecule, Amblyomin-X.  |  Pacheco, MT., et al. 2016. Exp Cell Res. 340: 248-58. PMID: 26748183
  5. Characterization of ciliobrevin A mediated dynein ATPase inhibition on flagellar motility of Leishmania donovani.  |  Reddy, GS., et al. 2017. Mol Biochem Parasitol. 214: 75-81. PMID: 28389272
  6. Effect of inhibition of axonemal dynein ATPases on the regulation of flagellar and ciliary waveforms in Leishmania parasites.  |  Mukhopadhyay, AG. and Dey, CS. 2018. Mol Biochem Parasitol. 225: 27-37. PMID: 30145318
  7. Ciliary Mechanism of Regulating Hedgehog and Wnt/β-Catenin Signaling Modulates Ultraviolet B Irradiation-Induced Photodamage in HaCaT Cells.  |  Shen, T., et al. 2019. J Biomed Nanotechnol. 15: 196-203. PMID: 30480526
  8. Evodiamine Augments NLRP3 Inflammasome Activation and Anti-bacterial Responses Through Inducing α-Tubulin Acetylation.  |  Li, CG., et al. 2019. Front Pharmacol. 10: 290. PMID: 30971927
  9. Analysis of the Structural Mechanism of ATP Inhibition at the AAA1 Subunit of Cytoplasmic Dynein-1 Using a Chemical 'Toolkit'.  |  Tati, S. and Alisaraie, L. 2021. Int J Mol Sci. 22: PMID: 34299323
  10. Primary Cilium by Polyinosinic:Polycytidylic Acid Regulates the Regenerative Migration of Beas-2B Bronchial Epithelial Cells.  |  Gweon, B., et al. 2022. Biomol Ther (Seoul). 30: 170-178. PMID: 35221299

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

HPI-4, 5 mg

sc-358720
5 mg
$136.00

HPI-4, 25 mg

sc-358720A
25 mg
$541.00